These Biotechs Are Awaiting FDA Rulings In November
October has seen the FDA approve the first drug for COVID-19 (remdesivir), the first treatment for Ebola virus (Regeneron Pharmaceuticals’ Inmazeb), and the first drug…
Biotech Investments
The Current Status – And Future Prospects – Of This COVID-19 Vaccine Partnership
In March, two small biotechs partnered to develop a vaccine for COVID-19 using a mechanism called RNA interference (RNAi) – and early data for the…
Why These 2 Overlooked Biotech Stocks Are Deserving Of Attention
“Both of these biotechs deserve a lot more attention than they’ve been receiving,” asserts the author of today’s article in regards to two clinical-stage biotech…
Biotech Penny Stocks To Buy (Or Bypass)
“Call it what you will, but I think traders who’ve dug into the biotech space initially came for the COVID, then figured out there’s far…
This Immuno-Oncology Stock Could Be A Compelling Short-Term Play (Or Long-Term Investment)
The clinical-stage biotech highlighted in today’s article – operating in the hot immuno-oncology sector – has both long-term and short-term bull cases to be made…
These 2 Biotechs Could Revolutionize Disease Treatment And Prevention – And Bring Big Rewards To Risk-Tolerant Investors
“One method of finding great stocks is to hunt down clinical stage companies with potential new treatment methods for diseases and ailments that affect large…
These 5 Stocks Are Popular With Robinhood Users And Analysts Alike
Of the most popular stocks on the Robinhood trading app, which boast the highest analyst ratings? Today’s article identifies the five most popular Robinhood stocks…
The Recent – And Future – Performance Of The Nasdaq Junior Biotechnology Index Amid The Coronavirus Pandemic
Noting that it launched against “perhaps the most consequential backdrop imaginable for the overall Biotech industry,” today’s article examines the recent performance of the Nasdaq…
A First-In-Kind Universal Influenza Vaccine Could Make This Small Biotech A Strong Buy
“Imagine the market for an influenza vaccine that would not require modifications each year to address annual mutations in the influenza virus, that brings about…
Assess Potential Biotech Plays With This Valuation Formula
With the biotech space red-hot right now amid the race for solutions to the COVID-19 crisis, how can traders assess potential biotech plays? Noting that…